Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Thursday, April 18, 2024

GBCI India certifies GKNM Hospital with the first LEED v4.1 Operations...

Coimbatore,  September 5, 2022: GBCI India, the nation’s foremost authority on sustainability in building design, construction, and operations, has announced that it has awarded...

Biotechnology

The Future is Here: MASSH Hospital Ushers in a New Era of Smart Healthcare

NEW DELHI , August 29, 2023:  A ground-breaking chapter in the realm of healthcare has unfolded with the official launch of Minimal Access Smart...

IT & Software Support

Appointments

Novartis India Limited reconstitutes Board; appoints Sanjay Murdeshwar as Vice Chairman & Managing Director

Mumbai, June 15, 2019: At a meeting held in Mumbai today, the Board of Directors of Novartis India Limited announced the appointment of Sanjay...

Awards

Gift Your Mother A ‘Me-Time’ With A Meditative Workshop

New Delhi, May 09, 2020: We all know that motherhood is a thankless job. It can leave the mother feeling inadequate, anxious and sometimes...

Financial Results

Syngene reports solid Q4 growth and ends the year on a strong note

Q4 revenue up 13% to Rs. 628 Cr, PAT up 20% to Rs 120...

Dr. Reddy’s Q1 FY20 Financial Results

Hyderabad, July 29, 2019: Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE:...

Approvals

Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has granted marketing authorization for...

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Molnupiravir for treating Covid-19 at Yashoda Hospitals Somajiguda, Hyderabad – Phase 3 trials

New Delhi, May 22, 2021: Hyderabad based Yashoda Hospitals in their Somajigida unit will start Phase III Trials in association with NatcoPharma who received...

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Maxivision Super Speciality Eye Hospitals signed a Memorandum of Understanding with the Government of...

Chennai, September 13, 2023:  Maxivision Super Speciality Eye Hospitals ("Maxivision"), one of India's leading and fastest-growing chain of private eye care hospitals signed a  Memorandum of Understanding with the Government of Tamil Nadu today to set up eye hospitals across...

Asian eyelid Blepharoplasty: a trend among north eastern patients to create eyelid crease

By Dr. Parag Telang, Plastic & Reconstructive Surgeon and Director of Designer Bodyz Centre for advanced cosmetic surgery Among people who have an indistinct crease...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Bio Innovations for Regenerative Agriculture

Hyderabad, November 02, 2021: Explaining the theme of the Bio-Agri 2021, India's biggest conference, "Bio Innovations for Regenerative Agriculture" Dr Venkatesh Devanur, Secretary of BIPA-Bio Agri...

Lupin Launches ‘Jan Kovid’ Helpline for Mumbai Citizens

Mumbai, May 07, 2020: Pharma major Lupin Limited (Lupin) today announced the launch of the 'Jan Kovid' Helpline (1800-572-6130) under the tagline 'Mann Ka Swaasthya,...

Dental Care

Hospital Management

HCG Cancer Hospital completes Comprehensive Genomic Profi­ling (CGP) of 1000+ Cancer Patients

Bengaluru , August 22, 2023: Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer...

Drug Discovery & Development

Suppliers

Technology

Batteries Designed for Space Robots Are Now Being Used in Hospitals

New Delhi, September 29, 2020: It’s important that during a space mission astronaut have reliable and anti-flammable lithium-ion batteries to assist them in maintaining...

Companies

Lung Cancer Screening: Who Should Consider It and Why?

Dr. Raj Nagarkar, MD & Chief Surgical Oncologist at HCG Manavata Cancer Centre Nasik  For those bravely facing the challenges of lung cancer, steering through the...

Marketing

Our Partners

Machinery & Equipments